Streetwise Reports' Article Archives — Current Month (13)
MindBio Therapeutics Positions Voice AI Technology for Growth in Safety-Critical Sectors (06/12/2026)
Explore how MindBio Therapeutics is advancing voice-based AI detection for intoxication across mining, aviation, and other industries, backed by strong market trends and analyst targets.
MindBio Therapeutics Advances AI Voice Tech for Workplace Safety in Growing Biotech and AI Detector Markets (06/12/2026)
MindBio Therapeutics delivers first prototype Edge AI kiosks for non-invasive intoxication and fatigue detection, positioning the company in high-growth sectors including mining, aviation, and construction, while analysts highlight significant upside potential.
Biopharma Co. Trials Precision Medicine Breakthrough for Dry Eye Disease. Gets Positive Results (06/12/2026)
Oculis Holding AG (OCS:NASDAQ; OCS:XICE) launches PREDICT-1, a genotype-based trial for licaminlimab, targeting 10M moderate-to-severe dry eye patients.
Biotech Firm Launches Massive AI Safety Solution for Zero-Tolerance Industries (06/11/2026)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) delivers first Edge AI intoxication detection kiosk prototypes for mining, aviation, and construction safety screening.
Biotech Firm Deploys Revolutionary Intox AI, Unlocking Billion-Dollar Industrial Safety Opportunity (06/10/2026)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) launches Intox AI, detecting intoxication via voice, targeting mining and aviation in a US$2.06B market.
ORIC Pharmaceuticals Positions for Growth in Expanding Oncology Market (06/10/2026)
Explore how ORIC Pharmaceuticals is advancing its oncology pipeline with key catalysts ahead, amid rising global demand for innovative cancer treatments and strong analyst support.
Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market (06/10/2026)
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools.
Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close (06/09/2026)
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.
Clinical-Stage Biopharma Co. Issues New Inducement Stock Options for Growth (06/08/2026)
ORIC Pharmaceuticals Inc. (ORIC:NASDAQ) granted 34,800 stock options and 5,900 restricted stock units to new employees as analysts issue "Buy" ratings for the year ahead.
Cancer Drug Developer Shifts 70% of Spending to Research as AI Pipeline Progresses (06/05/2026)
Rakovina Therapeutics (TSX.V: RKV) reported lower net losses, reduced administrative spending, debt restructuring, financing activity, and progress across its AI-driven oncology pipeline in Q1 2026.
From Healthcare IT Vendor to AI-Driven Holding Company (06/05/2026)
Healthcare Triangle Inc.'s (HCTI:NASDAQ) Spanish AI acquisition delivers US$34M in revenue and a near-US$40M agentic AI run rate, while shares still trade at just 1x cash.
California Pharma Co. Tests Breakthrough Cancer Drug, Cuts Death Risk 60% (06/04/2026)
Revolution Medicines Inc.'s (RVMD:NASDAQ) daraxonrasib treats pancreatic cancer patients, doubling median survival. Analysts rate it a "Buy" with targets up to US$263.
US Biotech Co. Targets Muscular Dystrophy with First-In-Class Drug (06/01/2026)
Capricor Therapeutics Inc.'s (CAPR:NASDAQ) Deramiocel targets FDA approval by August 2026, with analysts issuing Buy ratings and price targets as high as US$60.
More Archives
2025Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2024Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
